CA3127177A1 - Method for producing recombinant protein - Google Patents

Method for producing recombinant protein Download PDF

Info

Publication number
CA3127177A1
CA3127177A1 CA3127177A CA3127177A CA3127177A1 CA 3127177 A1 CA3127177 A1 CA 3127177A1 CA 3127177 A CA3127177 A CA 3127177A CA 3127177 A CA3127177 A CA 3127177A CA 3127177 A1 CA3127177 A1 CA 3127177A1
Authority
CA
Canada
Prior art keywords
protein
recombinant
cells
recombinant cells
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3127177A
Other languages
English (en)
French (fr)
Inventor
Kenji Nakahigashi
Li Jiang
Takanobu Noda
Kenji Tsuyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spiber Inc
Original Assignee
Spiber Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spiber Inc filed Critical Spiber Inc
Publication of CA3127177A1 publication Critical patent/CA3127177A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA3127177A 2019-01-31 2020-01-30 Method for producing recombinant protein Pending CA3127177A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019015716 2019-01-31
JP2019-015716 2019-01-31
JP2019-142388 2019-08-01
JP2019142388 2019-08-01
PCT/JP2020/003487 WO2020158877A1 (ja) 2019-01-31 2020-01-30 組換えタンパク質の製造方法

Publications (1)

Publication Number Publication Date
CA3127177A1 true CA3127177A1 (en) 2020-08-06

Family

ID=71840352

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3127177A Pending CA3127177A1 (en) 2019-01-31 2020-01-30 Method for producing recombinant protein

Country Status (8)

Country Link
US (1) US20220033870A1 (https=)
EP (1) EP3919506A4 (https=)
JP (2) JP6968468B2 (https=)
CN (1) CN113439087A (https=)
BR (1) BR112021014805A2 (https=)
CA (1) CA3127177A1 (https=)
SG (1) SG11202107697UA (https=)
WO (1) WO2020158877A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021020546A1 (ja) * 2019-08-01 2021-02-04 Ｓｐｉｂｅｒ株式会社 組換え細胞及び組換えタンパク質の製造方法
MX2024010846A (es) * 2022-03-24 2024-09-11 Richter Gedeon Nyrt Metodo para la preparacion de biofarmacos.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58110600A (ja) 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
JPS60221091A (ja) 1983-12-21 1985-11-05 Kyowa Hakko Kogyo Co Ltd 新規プロモ−タ−
JP2564268B2 (ja) 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
JP2545078B2 (ja) 1987-04-06 1996-10-16 協和醗酵工業株式会社 核酸関連物質の製造法
EP0326046A3 (en) 1988-01-25 1990-06-13 Takeda Chemical Industries, Ltd. Production of human epidermal growth factor
JPH0322979A (ja) 1989-06-19 1991-01-31 Kyowa Hakko Kogyo Co Ltd 新規プラスミノーゲン活性化因子
JP3012026B2 (ja) 1991-03-05 2000-02-21 ヒゲタ醤油株式会社 高発現ベクター及び該高発現ベクター を保有する微生物並びに該微生物を 用いる有用物質の製造法
JP3433807B2 (ja) 1992-03-31 2003-08-04 鵜高 重三 新規アミノ酸配列及び該アミノ酸配列をコードするｄｎａを保有する発現ベクターを組み込んだバチルス・ブレビスを用いる有用物質の製造法
JP2727391B2 (ja) 1992-07-23 1998-03-11 ヒゲタ醤油株式会社 高発現ベクター及び該高発現ベクターを保有する微生物並びに該微生物を用いる有用物質の製造法
JP2771756B2 (ja) 1993-04-09 1998-07-02 東洋エンジニアリング株式会社 組換え大腸菌の培養方法
AU3584500A (en) * 1999-01-27 2000-08-18 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in escherichia coli
JP3753945B2 (ja) 2001-02-14 2006-03-08 ヒゲタ醤油株式会社 大腸菌とブレビバチルス属細菌間のプラスミドシャトルベクター
CN101712955B (zh) * 2002-03-06 2013-06-05 东丽株式会社 利用基因重组蚕生产生理活性蛋白质的方法
KR100499647B1 (ko) * 2002-09-25 2005-07-05 한국과학기술원 박테리아에서의 외래단백질의 생산성을 증가시키는 방법
KR20090031359A (ko) * 2006-05-16 2009-03-25 교와 핫꼬 기린 가부시키가이샤 단백질의 고분비 생산 방법
BRPI0701826B1 (pt) * 2007-03-16 2021-02-17 Embrapa - Empresa Brasileira De Pesquisa Agropecuária proteínas da teia de aranha nephilengys cruentata, avicularia juruensis e parawixia bistriata isoladas da biodiversidade brasileira
EP3147369B1 (en) * 2014-05-21 2025-08-06 Ajinomoto Co., Inc. Fibroin-like protein production method
CN105331568B (zh) * 2014-06-12 2019-01-04 清华大学 一种通过增大细菌体积而增加微生物胞内内含物积累量的方法
JP7452830B2 (ja) * 2016-08-02 2024-03-19 Ｓｐｉｂｅｒ株式会社 組換えタンパク質の生産方法

Also Published As

Publication number Publication date
JP2021101744A (ja) 2021-07-15
EP3919506A1 (en) 2021-12-08
CN113439087A (zh) 2021-09-24
JP6968468B2 (ja) 2021-11-17
BR112021014805A2 (pt) 2022-01-04
US20220033870A1 (en) 2022-02-03
WO2020158877A1 (ja) 2020-08-06
SG11202107697UA (en) 2021-08-30
EP3919506A4 (en) 2022-11-02
JP7526489B2 (ja) 2024-08-01
JPWO2020158877A1 (ja) 2021-02-18

Similar Documents

Publication Publication Date Title
EP3502169B1 (en) Composite molding composition including fibroin-like protein, and method for producing composite molding composition
EP3476859A1 (en) Modified fibroin
JP7452830B2 (ja) 組換えタンパク質の生産方法
KR20120076346A (ko) 실크 도프의 제조 방법
JP2022081664A (ja) フィブロイン様タンパク質の製造法
JP7526489B2 (ja) 組換えタンパク質の製造方法
TW201726702A (zh) 生產胰島素之方法
AU2018241920B2 (en) Recombinant host cell with altered membrane lipid composition
JP2003500056A (ja) 分子シャペロンを用いるタンパク質コンホメーションの調節方法
EP2831262A1 (en) Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly
Buchner Bacterial Hsp90–desperately seeking clients.
US20220195479A1 (en) Method for producing recombinant protein
WO2021020546A1 (ja) 組換え細胞及び組換えタンパク質の製造方法
EP3536784A1 (en) Host cell engineered for improved metabolite production
WO2020158874A1 (ja) 組換えタンパク質の製造方法
JP7762935B2 (ja) 組換え細胞、発現構築物、及び組換えタンパク質の製造方法
US11851684B2 (en) Expression cassette
WO2021015153A1 (ja) 改変フィブロイン
WO2021241546A1 (ja) 目的タンパク質の製造方法
JP2020080727A (ja) 目的タンパク質の製造方法
US12319718B2 (en) Modified fibroin
KR102031886B1 (ko) 신규한 프로모터 및 이의 용도
US20220332993A1 (en) Protein Adhesive, Joined Body, and Method for Producing the Same
Salehzadeh et al. Intracellular expression of human calcitonin (hCT) gene in the methylotrophic yeast, Pichia pastoris
KR20120079653A (ko) 소 유래의 신규한 인슐린 유사 성장 인자-ｉ 및 이를 암호화하는 유전자

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20231207

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241205

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241205

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241205

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250523

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250911

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251202

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251202

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251224

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251224

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251224

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE

Effective date: 20260331

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260331

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260402